Search Browse Earnings

ESSA Pharma Inc. — SlamSEC

ESSA Pharma Inc.

EPIX

Pharmaceutical Preparations·VANCOUVER

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Parkinson David Ross

CFO

Wood David S.

Revenue

—

Adj. EBITDA

—

Net Income

-$26.6M

FY 2024

EPS (Diluted)

-$0.60

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$33.7M

FY 2024

Total Debt

—

Net Cash

$33.7M

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—